Home » Topics » Science » New compound

New compound
RSS

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Merck Frosst discovers orally active COX-2 inhibitors

Jan. 24, 1997

Merck & Co. investigates thrombin inhibitors

Jan. 24, 1997

Thrombin inhibitors submitted to SAR studies at DuPont Merck

Jan. 24, 1997

Glaxo Wellcome selects anticonvulsant compound for further study

Jan. 24, 1997

New tool for studying phosphodiesterase receptors

Jan. 23, 1997

New AMPA receptor modulator described by Servier

Jan. 23, 1997

Neuroprotective agent described by Taisho

Jan. 16, 1997

Schering-Plough develops dual PAF and histamine antagonist

Jan. 16, 1997

New analgesic agent described by Japanese academics

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...